ArticleCase reports in oncology

Successful Response to First-Line Carboplatin, Pemetrexed, and Bevacizumab for Peritoneal Mesothelioma: Two Case Reports.

Tomonobu Koizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.